David Onions
Directeur Technique/Scientifique/R&D chez BioReliance Corp.
Profil
David Onions is currently the Director & Chief Scientific Officer at BioReliance Corp.
He is also a Director at AUSTRIANOVA Biomanufacturing AG and a Principal at the University of Glasgow.
Previously, he was a Director at Q-One Biotech Ltd.
and the Chief Medical Officer at Invitrogen Corp.
He holds a doctorate from the University of Cambridge and an undergraduate degree from the University of Bristol.
Postes actifs de David Onions
| Sociétés | Poste | Début |
|---|---|---|
| University of Glasgow | Corporate Officer/Principal | - |
BioReliance Corp.
 BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | Directeur Technique/Scientifique/R&D | 18/06/2007 |
AUSTRIANOVA Biomanufacturing AG
 AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Directeur/Membre du Conseil | - |
Anciens postes connus de David Onions
| Sociétés | Poste | Fin |
|---|---|---|
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Directeur Technique/Scientifique/R&D | 25/11/2008 |
| Q-One Biotech Ltd. | Directeur/Membre du Conseil | 01/07/2003 |
Formation de David Onions
| University of Cambridge | Doctorate Degree |
| University of Bristol | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
BioReliance Corp.
BioReliance Corp. Pharmaceuticals: MajorHealth Technology BioReliance Corp. provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies. It provides outsourced services to customers from most healthcare disciplines, including pharmaceutical, biopharmaceutical and chemical companies in the world. The firm also provides safety testing services focused on the rapidly growing biologics sector of the pharmaceutical and biotechnology industries. The company enables emerging and clinical stage companies who may lack the staff, expertise and financial resources to conduct many aspects of product development in-house. BioReliance was founded by Charles E. Bender in 1947 and is headquartered in Rockville, MD. | Health Technology |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Invitrogen develops, manufactures and markets research tools in kit form and provides other research products and services to corporate, academic and government entities. These research kits simplify and improve gene cloning, gene expression and gene analysis techniques. | Electronic Technology |
| Q-One Biotech Ltd. | Health Technology |
AUSTRIANOVA Biomanufacturing AG
AUSTRIANOVA Biomanufacturing AG BiotechnologyHealth Technology AUSTRIANOVA Biomanufacturing AG engages in the developmente of proprietary drug delivery technologies in orphan niche indications in oncology. It offers NovaCaps, which targets tumours in pancreatic cancer. The company was founded in 2001 and is headquartered in Vienna, Austria. | Health Technology |
